In cell proliferation experiments, both the selective β1-AR antagonist ATE and β2-AR antagonist ICI significantly blocked E-induced cell proliferation (Fig. 6A), indicating the involvement of both β-AR subtypes in promoting tumor cell proliferation. The gene discussed is ADRB1; the disease is neoplasm.